Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Bo Rui Medicine: BGM0504 Tablets Granted Approval for Drug Clinical Trial
36Kr reports that Bo Rui Medicine announced its wholly-owned subsidiary, Bo Rui Pharmaceutical, recently received the "Notice of Approval for Drug Clinical Trials" issued by the National Medical Products Administration. The approval permits clinical trials of BGM0504 tablets in adults with type 2 diabetes.
Read the full article at 36KrRelated coverage
Tech to Replace Animal Testing Is Almost Ready. Scientists Are Not
IEEE Spectrum · Sep 29, 2026
Bill Gates Will NOT And CANNOT Inject Us With A Microchip In A Vaccine - Fails Basic Fact Check
science20.com · Aug 20, 2026
Forbes Asia 100 To Watch 2026
forbes.com · Aug 24, 2026
EQS - News: Chainwire: INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer Drug Research and Explore New Applications for XPro
finanznachrichten.de · Oct 16, 2026